The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2022 | ISA session highlights: basic research on light chains & cardiotoxicity in amyloidosis
Stefano Ricagno, PhD, University of Milan, Milan, Italy, shares his highlights from the session on basic research on light chains and cardiotoxicity that took place at this year’s ISA meeting, discussing the role of post-translational modifications (PTMs) as a risk factor for AL amyloidosis, and how it is possible to predict amyloidogenic proteins from sequence motifs. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
